Role of Intestinal Bacteria in Human Norovirus Infection

肠道细菌在人类诺如病毒感染中的作用

• 批准号: 9416071
• 负责人: Stephanie M Karst
• 金额: $ 36.88万
• 依托单位: UNIVERSITY OF FLORIDA
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-02-16 至 2020-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9416071
• 关键词: Antibiotics; Antibodies; Antigens; Antiviral Agents; Autoimmune Process; B-Lymphocytes; Bacteria; Binding; Biological Models; Blood Group Antigens; Bystander Suppression; Carbohydrates; Cell Culture System; Cells; Charge; Childhood; Clinical; Complex; Cytokine Activation; Data; Developing Countries; Development; Diarrhea; Disease Outbreaks; Enteral; Enterobacteriaceae; Environment; Epidemic; Epithelial Cells; Excision; Exclusion; Filtration; Gastroenteritis; Genetic Polymorphism; Goals; Heterophile Antigens; Human; Human poliovirus; Immune; Immune response; Immunity; Immunoglobulin A; Immunologic Adjuvants; Immunosuppression; In Vitro; Infection; Inflammation; Intestinal Secretions; Intestines; Knowledge; Life Cycle Stages; Ligands; Mediating; Modeling; Molecular; Mouse Mammary Tumor Virus; Mucous Membrane; Mus; Norovirus; Organism; Pathogenesis; Positioning Attribute; Predisposition; Primary Infection; Process; Regulatory T-Lymphocyte; Reovirus; Research; Role; Series; System; Testing; Therapeutic; Treatment Efficacy; United States; Vaccines; Viral; Virion; Virus; Virus Diseases; Work; antiviral immunity; base; combat; commensal bacteria; cytokine; design; effective therapy; experimental study; foodborne; gut bacteria; immunogenicity; immunoregulation; improved; in vivo; infected B cell; insight; intestinal epithelium; microbial; mouse model; novel; practical application; prevent; public health relevance; response; stool sample; transcytosis; vaccine efficacy; vector

 DESCRIPTION (provided by applicant): Noroviruses are a significant cause of epidemic and sporadic gastroenteritis worldwide. They are the leading cause of severe childhood diarrhea in the United States and a major cause of severe childhood diarrhea in developing nations. Thus, development of effective vaccines and therapeutics is a critical need. The major barrier to this development has been the inability to culture human noroviruses. We have made two remarkable discoveries to overcome this obstacle - (1) human noroviruses infect B cells; and (2) they require enteric bacteria for optimal infection. Using the well-developed murine model of norovirus infection, we have validated both of these features of infection in an in vivo setting. Moreover, both of these findings provide fundamentally important clues to understanding norovirus pathogenesis and to developing effective strategies to combat infection. We speculate that human noroviruses interact with commensal bacteria in the gut lumen and virus:bacteria complexes are transcytosed across the intestinal epithelium in order to access the underlying B cell targets. During this process, the commensal bacteria should be recognized by mucosal immune cells and stimulate a tolerogenic microenvironment. In this environment, development of immune responses to the virus should be curbed through a process termed bystander suppression. This model is supported by the long- standing knowledge that norovirus infections are noninflammatory and they fail to elicit robust protective immunity. Understanding the basis for this apparent weak immunogenicity is key to designing effective treatment approaches. The objectives of the proposed research are thus to elucidate the mechanism by which enteric bacteria facilitate norovirus infection of B cells (Specific Aim 1); and the immune consequences of this interaction (Specific Aim 2).

 描述（由申请方提供）：诺如病毒是全球流行性和散发性胃肠炎的重要原因。它们是美国严重儿童腹泻的主要原因，也是发展中国家严重儿童腹泻的主要原因。因此，开发有效的疫苗和治疗剂是迫切需要的。这种发展的主要障碍是无法培养人诺如病毒。为了克服这一障碍，我们已经取得了两个显著的发现-（1）人类诺如病毒感染B细胞;（2）它们需要肠道细菌进行最佳感染。使用发达的诺如病毒感染的鼠模型，我们已经在体内环境中验证了感染的这两个特征。此外，这两项发现为了解诺如病毒的发病机制和制定有效的抗感染策略提供了重要的线索。我们推测，人类诺如病毒与肠道内的肠道细菌相互作用，病毒：细菌复合物被跨肠上皮细胞转运，以接近潜在的B细胞靶点。在此过程中，肠道细菌应被粘膜免疫细胞识别并刺激致耐受性微环境。在这种环境下，对病毒的免疫反应的发展应该通过称为旁观者抑制的过程来抑制。该模型得到了长期知识的支持，即诺如病毒感染是非炎症性的，并且它们不能引起强大的保护性免疫。理解这种明显弱免疫原性的基础是设计有效治疗方法的关键。因此，拟议研究的目的是阐明肠道细菌促进诺如病毒感染B细胞的机制（具体目标1）;以及这种相互作用的免疫后果（具体目标2）。